• Middle East
  • North Africa
  • Global
  • Business
  • Finance
  • Technology
  • Press
  • About Us
    • Press Release Distribution Services
    • Submit Press Release
    • Contact Us
Submit Press Release
Search
Close
Search
Close
Home Press

Liquid Biopsy in Breast Cancer Market Worth $411.1 Million

admin by admin
January 14, 2022
in Press
Share on FacebookShare on Twitter


(EMAILWIRE.COM, January 13, 2022 ) According to a new market research report Liquid Biopsy in Breast Cancer Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison (NGS, PCR), Competitive Landscape (Acquisition, Mergers, Collaboration, Competitive technology) – Global Forecasts to 2022, published by MarketsandMarkets™, the market is expected to reach USD 411.1 million by 2022 from USD 145.4 million in 2017, at a CAGR of 23.1%.

Browse 15 market data Tables and 11 Figures spread through 82 Pages and in-depth TOC on “Breast Cancer Liquid Biopsy Market”

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=150106081

The key factors driving the growth of this market include increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D.

By circulating biomarkers, cell-free DNA (cfDNA) is expected to account for the largest market share in 2017

Based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. In 2017, the cfDNA segment is expected to account for the largest share of the Liquid Biopsy in Breast Cancer Market. The ability of cfDNA for easy and early assessment of patient prognosis and occurrence in other body fluids along with blood is driving the growth of the cfDNA segment in the Breast Cancer Liquid Biopsy Market.

By end user, the reference laboratories segment accounted for the largest market share in 2017

Based on end user, the Liquid Biopsy in Breast Cancer Market is segmented into reference laboratories, hospitals and physician laboratories, and other end users (research institutes, public health laboratories, pathology laboratories, and small molecular laboratories). Reference laboratories form the largest and fastest-growing end-user segment of the liquid biopsy market. The large share of this segment is attributed to the increasing volume of liquid biopsy test samples outsourced to reference laboratories owing to their well-equipped set up for genetic testing.

North America dominated the market in 2017

North America accounted for the largest share of the Breast Cancer Liquid Biopsy Market in 2017, followed by Europe. A number of factors such as the easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS) among healthcare professionals, rising prevalence of breast cancer in the US and Canada, technological advancements in breast cancer liquid biopsy products, and growing public and private funding to support research activities in the field of liquid biopsy are aiding market growth in the region.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=150106081

The key players in the global Liquid Biopsy in Breast Cancer Market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com



Source link

Previous Post

Fiberglass Mold Market worth $468 million by 2024

Next Post

Cardiac Marker Testing Market worth $5.5 billion by 2025

RelatedPosts

Methyl Soyate Market expected to hit USD1.57 Bn by 2029 throughout the forecast period
Press

Methyl Soyate Market expected to hit USD1.57 Bn by 2029 throughout the forecast period

 (EMAILWIRE.COM, March 20, 2023 ) Pune 6 Mar 2023: As per the Maximize Market research, a global business...

by admin
March 20, 2023
Press

Electric Aircraft Market Worth $37.2 billion in 2030 at a CAGR of 19.8%

(EMAILWIRE.COM, March 20, 2023 ) The Electric Aircraft Market report provides an analysis of the market from 2022...

by admin
March 20, 2023
Award Ceremony Celebrates Best in LGBTQ Culture and Media!
Press

Award Ceremony Celebrates Best in LGBTQ Culture and Media!

   (EMAILWIRE.COM, March 20, 2023 ) LOS ANGELES - The top LGBTQ performers, celebrities and influentials turned out for...

by admin
March 20, 2023
Network Transformation Market expected to grow at a CAGR of 41.7 percent during the forecast period
Press

Network Transformation Market expected to grow at a CAGR of 41.7 percent during the forecast period

 (EMAILWIRE.COM, March 20, 2023 ) Pune 8 Mar 2023: As per the Maximize Market research, a global business...

by admin
March 20, 2023
Load More

Advertize

Latest Post

Giordano celebrates 30 years of operations in the Middle East          

Giordano celebrates 30 years of operations in the Middle East          

by admin
March 20, 2023

Global Video Management System (VMS) Market to Reach $21 Billion by 2027

Global Image Sensors Market to Reach $43.7 Billion by 2030

by admin
March 20, 2023

WorldVest Launches Africa Gold Corporation to Finance Gold Production

WorldVest Launches Africa Gold Corporation to Finance Gold Production

by admin
March 20, 2023

Informatic program to help drug discovery in Africa – Technology Today

by admin
March 20, 2023

BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East

Correction: BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East

by admin
March 20, 2023

Weekly Political Compass 3.20.23 | Teneo

Weekly Political Compass 3.20.23 | Teneo

by admin
March 20, 2023

MENANEWS provides press release distribution services for businesses, organizations and other entities with the need to reach media outlets in Europe, Middle east and Africa (MENANEWS) Submit press release or contact us today.

Share us

Subscribe To Our Newslatter

    • Middle East
    • North Africa
    • Global
    • Business
    • Finance
    • Technology
    • Press
    • About Us
      • Press Release Distribution Services
      • Submit Press Release
      • Contact Us
    Menu
    • Middle East
    • North Africa
    • Global
    • Business
    • Finance
    • Technology
    • Press
    • About Us
      • Press Release Distribution Services
      • Submit Press Release
      • Contact Us

    Browse by Category-

    Middle-East/ North Africa/ Global/ Business/ Finance / Technology/ Press/ About Us / PR Services / Submit PR / Contact us

    © 2023 Copyright MENANEWS

    Share us

    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Share on pinterest
    Pinterest